Make your products visible globally with Elite Membership.
I agree to the terms and conditions
Existing User?
Sign In with Email
Remember Me Forgot Password?
New User?
Enter your registered Email ID to get reset password.
Elite Member
Individual Register
LEVERKUSEN, GERMANY: Bayer signed an agreement to acquire 100 per cent of the shares of Steigerwald Arzneimittelwerk GmbH, Darmstadt, Germany, a privately held pharmaceutical company specializing in pharmacy - only herbal medicines. Steigerwald’s product portfolio includes Iberogast for the treatment of functional gastrointestinal disorders and Laif for the treatment of mild to moderate depression. Financial details have not been disclosed. The transaction is subject to fulfillment of the usual conditions, including antitrust clearance, and is expected to close at the beginning of July 2013.
“This transaction is further evidence of our commitment to augment organic growth with strategic bolt-on acquisitions. It will allow us to provide consumers with an even broader range of self-care options. This acquisition broadens our product offering for the treatment of gastrointestinal disorders and gives us the opportunity to enhance our presence in Germany, the fast-growing regions of East-Central Europe, and the CIS countries,” said Dr Marijn Dekkers, CEO, Bayer AG.
© WOC News
Login
DES PLAINES, US: UOP LLC, a Honeywell company, has been selected to provide technology for the world’s largest on-purpose propylene prod ...
MULHEIM AN DER RUHR, GERMANY: Brenntag, the global market leader in chemical distribution, has signed a purchase agreement to acquire the dist ...
HONG KONG, CHINA: DKSH’s Business Unit Healthcare has successfully signed an agreement with GlaxoSmithKline (GSK) to provide contract sales serv ...
PARIS, FRANCE/ALBERTA, CANADA: Technip was awarded by NOVA Chemicals Corporation the detail engineering, and procurement services contract for the p ...
TOKYO, JAPAN: Toyo Engineering Corporation was awarded a contract from Sasol North America Inc to provide Front End Engineering Design (FEED) services ...
LUDWIGSHAFEN, GERMANY: With three separate transactions, BASF has strengthened its technology footprint in industrial enzymes, one of BASF’s ide ...
Stay updated with the latest chemical industry trends and innovations.
Verification Code has been sent to
Please enter the Verification Code below to verify your Email Address.If you cannot see the email from "noreply@worldofchemicals.com" in your inbox,make sure to check your SPAM Folder